Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: kyleena

  • Vaginally Inserted Contraceptives Can Fill Care Gap for Some

    Women around the world lack awareness about most of the vaginally inserted contraceptive methods. This poses the biggest barrier to their use, researchers found. Product cost is another major barrier to adoption, as are unsupportive partner attitudes and women’s concerns about insertion. The most important enabling factor to a person’s use of vaginally inserted contraceptives is counseling from a trained provider or community health worker.

  • LARC Options Expand With New Intrauterine Device

    Family planning clinicians are adding another choice to the expanding list of long-acting reversible contraceptive options with the September 2016 FDA approval of the Kyleena 19.5 mg levonorgestrel IUD from Whippany, NJ-based Bayer HealthCare Pharmaceuticals. The new IUD is available as of October 2016 by prescription only.

  • FDA Approves IUS Contraceptive For Up to Five Years

    The FDA approved Kyleena, a levonorgestrel-releasing, progestin-containing IUS, for up to five years.